Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JFXTF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN114917361A ADC-23
|
|||||
| Synonyms |
CN114917361A_ADC-23
Click to Show/Hide
|
|||||
| Organization |
Bayer Pharma AG
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 4 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
Colorectal cancer [ICD11:2B91]
Investigative
Endometrial cancer [ICD11:2C76]
Investigative
Glioblastoma [ICD11:2A00]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.5
|
|||||
| Antibody Name |
Anti?TWEAKR mAb
|
Antibody Info | ||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
CN114917361A ADC-23 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.